Abstract
The objective of the present study was to determine whether lesion of the subthalamic nucleus (STN) promoted by N-methyl-D-aspartate (NMDA) would rescue nigrostriatal dopaminergic neurons after unilateral 6-hydroxydopamine (6-OHDA) injection into the medial forebrain bundle (MFB). Initially, 16 mg 6-OHDA (6-OHDA group) or vehicle (artificial cerebrospinal fluid - aCSF; Sham group) was infused into the right MFB of adult male Wistar rats. Fifteen days after surgery, the 6-OHDA and SHAM groups were randomly subdivided and received ipsilateral injection of either 60 mM NMDA or aCSF in the right STN. Additionally, a control group was not submitted to stereotaxic surgery. Five groups of rats were studied: 6-OHDA/NMDA, 6-OHDA/Sham, Sham/NMDA, Sham/Sham, and Control. Fourteen days after injection of 6-OHDA, rats were submitted to the rotational test induced by apomorphine (0.1 mg/kg, ip) and to the open-field test. The same tests were performed again 14 days after NMDA-induced lesion of the STN. The STN lesion reduced the contralateral turns induced by apomorphine and blocked the progression of motor impairment in the open-field test in 6-OHDA-treated rats. However, lesion of the STN did not prevent the reduction of striatal concentrations of dopamine and metabolites or the number of nigrostriatal dopaminergic neurons after 6-OHDA lesion. Therefore, STN lesion is able to reverse motor deficits after severe 6-OHDA-induced lesion of the nigrostriatal pathway, but does not protect or rescue dopaminergic neurons in the substantia nigra pars compacta.
Highlights
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that results from a loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) [1]
We determined whether subthalamic nucleus (STN) lesion-induced motor recovery could be explained by the rescue of nigrostriatal dopaminergic neurons in a 6-OHDA-lesion rat model of PD
Our results show that STN lesion performed 15 days after 6-OHDA lesion of the nigrostriatal pathway reduced the apomorphine-induced rotational behavior
Summary
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that results from a loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) [1]. The degeneration of mesencephalic dopaminergic cells causes significant dopamine (DA) depletion in the corpus striatum, leading to debilitating motor dysfunction when DA reduction is greater than 80% [2]. PD symptoms include akinesia, rigidity, resting tremor, slow movement, gait dysfunction, and postural instability [3]. The striatal DA deficit leads to the disinhibition of the indirect pathway of the basal ganglia circuit.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Brazilian Journal of Medical and Biological Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.